Cargando…
Discontinuation of Levetiracetam and Valproic Acid Due to Adverse Effects in Early Post-traumatic Seizure Prophylaxis
Introduction: Levetiracetam (LEV) and valproic acid (VPA) are two anti-epileptic drugs (AEDs) routinely used for post-traumatic seizure (PTS) prophylaxis at our institution. In our practice, VPA is used for its beneficial effects on behavioral agitation and headaches, but it is also associated with...
Autores principales: | Pathak, Sami M, Ziechmann, Robert, Menzer, Jacob, Hoeft, Ava, Villanueva, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676217/ https://www.ncbi.nlm.nih.gov/pubmed/38021754 http://dx.doi.org/10.7759/cureus.47742 |
Ejemplares similares
-
A Comparison of Seizure Prophylaxis: Phenytoin Versus Levetiracetam
por: Fiani, Brian, et al.
Publicado: (2021) -
The Concurrent Use of Phenytoin and Levetiracetam for Seizure Prophylaxis in ICU Patients: The “Arrowhead Rationale”
por: Wong, Meghan, et al.
Publicado: (2023) -
Levetiracetam for Pediatric Posttraumatic Seizure Prophylaxis
por: Nita, Dragos A., et al.
Publicado: (2016) -
Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients
por: Kirmani, Batool F., et al.
Publicado: (2013) -
Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
por: Kuo, Cheng-Yen, et al.
Publicado: (2020)